Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 09 Jan 2026 for SELLAS Life Sciences Group, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David A. Scheinberg: trading record in brief
Filings by David A. Scheinberg span 2 companies, the busiest being Progenics Pharmaceuticals Inc and SELLAS Life Sciences Group, Inc. Between 27 February 2006 and 7 January 2026, the trades on record add up to 37 filings.
Sales make up the whole of the open-market record (10 sales, €1.2M). Besides market trades, the filings include 9 share grants and 18 option exercises.
The latest filing, published on 9 January 2026, reports a share grant in SELLAS Life Sciences Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David A. Scheinberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
50,000 shares0Common StockSEC:0001104659-26-002509:0
12,500 shares0Common StockSEC:0001104659-25-003499:0
6,000 shares0Common StockSEC:0001104659-24-006407:0
2,500 shares0Common StockSEC:0001104659-23-010619:0
1,900 shares0Common StockSEC:0001104659-22-010393:0
5 of 5 declarations
